Incretin receptor agonist research
GLP-1 S
Molecular data
- Sequence
- Single-receptor incretin class agonist (full identity on COA)
- Purity
- ≥ 99.0%
- Lot number
- Assigned at shipment
Certificate of Analysis
Independent third-party verified
- Purity (HPLC)
- 99.81%
- Batch
- SEM20-052026R2
- Laboratory
- Freedom Diagnostics
- Analyzed
- Jun 9, 2026
Summary
≥99% by HPLC · from $39 (single) to $95 (10-pack)
Single-receptor incretin class agonist studied in incretin-pathway metabolic research.
Read the full GLP-1 S compound profile — mechanism, published research, and references →
Research context
Drucker, Cell Metab (2018). Class-level GLP-1R pharmacology reviews. Müller et al., Mol Metab (2019).
More in Incretin Receptor Agonists
Handling & reference
- Mono, dual and triple incretin agonists comparedThe incretin compounds differ by how many receptors they engage — one, two or three. What that architecture means, and how to verify which molecule is in the vial.
- How to read a peptide Certificate of Analysishow to read a Certificate of Analysis
- HPLC vs mass spec vs amino acid analysis — what each test provesA practical guide to the three peptide QC methods, what each can prove and disprove, and why a complete QC profile requires all three.
- Made in the USA, and what that actually meansWhere our peptides are made, how we vet the active ingredient, and why independent per-lot testing matters more than any origin claim.
Published research
Primary literature on this compound — trial design, endpoints and limitations. Summaries, not recommendations.
- Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2)Lancet · 2021
- Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesN Engl J Med · 2021
- Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3)JAMA · 2021
- Once-Weekly Semaglutide in Adults with Overweight or ObesityN Engl J Med · 2021
- Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesN Engl J Med · 2016
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 DiabetesN Engl J Med · 2016
About GLP-1 S
- What is GLP-1 S?
- Single-receptor incretin class agonist studied in incretin-pathway metabolic research.
- What research context is GLP-1 S studied in?
- Drucker, Cell Metab (2018). Class-level GLP-1R pharmacology reviews. Müller et al., Mol Metab (2019).
- What's included with each GLP-1 S lot?
- Every lot of GLP-1 S ships with a per-lot Certificate of Analysis (COA) from an independent US laboratory documenting ≥99.0% purity by HPLC and mass-spectrometry identity confirmation. The COA is QR-linked from the vial label.
- How is GLP-1 S verified?
- Each lot of GLP-1 S is independently verified at Chromate.org, a US analytical laboratory, with HPLC purity, mass-spectrometry identity, and heavy-metal screening. The per-lot Certificate of Analysis is published on this page and ships printed in every package.
- How is GLP-1 S stored?
- Lyophilized GLP-1 S is shipped at ambient temperature in protective packaging. For long-term laboratory storage, refer to the per-lot Certificate of Analysis storage notes specific to the lot you receive.
- Is GLP-1 S approved for human or veterinary use?
- No. This product is for laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or medical device. Customers certify research use at checkout per our Terms of Sale.
Research use only
This product is for laboratory research use only. Not for human or veterinary use. Not a drug, supplement, or medical device. By purchasing, customer certifies research use per our Terms of Sale.